Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian Giles

Showing results (21-30 of 73) with videos related to

Pageof 8
Sort By:
Rheumatology (Oxford, England)|March 15, 2011
The efficacy of repeated treatment with B-cell depletion therapy in systemic lupus erythematosus: an evaluationTabitha Turner-Stokes, Tim Y Lu, Michael R Ehrenstein, et al.
Autoimmunity Reviews|April 10, 2025
The impact of pregnancy on future health in Rheumatoid Arthritis: A systematic review of the literatureBethan Goulden, George Woodward, Sophie Leiner, et al.
Molecular Immunology|December 23, 2003
Somatic mutations to arginine residues affect the binding of human monoclonal antibodies to DNA, histones, SmD and Ro antigenJoanna Haley, Lesley J Mason, Sylvia Nagl, et al.
BMC Biotechnology|November 19, 2015
Development of a high yield expression and purification system for Domain I of Beta-2-glycoprotein I for the treatment of APSThomas McDonnell, Charis Pericleous, Emmanuelle Laurine, et al.
Rheumatology (Oxford, England)|July 2, 2019
Antiphospholipid antibody levels in early systemic lupus erythematosus: are they associated with subsequent mortality and vascular events?Charis Pericleous, Amrita D'Souza, Thomas McDonnell, et al.
Clinical and Experimental Rheumatology|May 24, 2023
DAS28(3)CRP is a reliable measure of disease activity in pregnant women with rheumatoid arthritisCharles Raine, Coziana Ciurtin, Elizabeth C Jury, et al.
Rheumatology Advances in Practice|October 26, 2022
The BILAG2004-Pregnancy Index is a valid disease activity outcome measure for pregnant SLE patientsChee-Seng Yee, Munther Khamashta, Mohammed Akil, et al.
Blood Reviews|September 1, 2019
The role of beta-2-glycoprotein I in health and disease associating structure with function: More than just APSThomas McDonnell, Chris Wincup, Ina Buchholz, et al.
Wellcome Open Research|December 28, 2020
Play attention! Therapeutic aspects to play in delirium prevention and managementMichaela Lynn, Bethan Goulden, Meera Parmar, et al.
Rheumatology (Oxford, England)|July 6, 2012
The BILAG2004-Pregnancy index is reliable for assessment of disease activity in pregnant SLE patientsChee-Seng Yee, Mohammed Akil, Munther Khamashta, et al.
Pageof 8

Showing results (21-30 of 73) with videos related to

Sort By:
Pageof 8
Rheumatology (Oxford, England)|March 15, 2011
The efficacy of repeated treatment with B-cell depletion therapy in systemic lupus erythematosus: an evaluationTabitha Turner-Stokes, Tim Y Lu, Michael R Ehrenstein, et al.
Autoimmunity Reviews|April 10, 2025
The impact of pregnancy on future health in Rheumatoid Arthritis: A systematic review of the literatureBethan Goulden, George Woodward, Sophie Leiner, et al.
Molecular Immunology|December 23, 2003
Somatic mutations to arginine residues affect the binding of human monoclonal antibodies to DNA, histones, SmD and Ro antigenJoanna Haley, Lesley J Mason, Sylvia Nagl, et al.
BMC Biotechnology|November 19, 2015
Development of a high yield expression and purification system for Domain I of Beta-2-glycoprotein I for the treatment of APSThomas McDonnell, Charis Pericleous, Emmanuelle Laurine, et al.
Rheumatology (Oxford, England)|July 2, 2019
Antiphospholipid antibody levels in early systemic lupus erythematosus: are they associated with subsequent mortality and vascular events?Charis Pericleous, Amrita D'Souza, Thomas McDonnell, et al.
Clinical and Experimental Rheumatology|May 24, 2023
DAS28(3)CRP is a reliable measure of disease activity in pregnant women with rheumatoid arthritisCharles Raine, Coziana Ciurtin, Elizabeth C Jury, et al.
Rheumatology Advances in Practice|October 26, 2022
The BILAG2004-Pregnancy Index is a valid disease activity outcome measure for pregnant SLE patientsChee-Seng Yee, Munther Khamashta, Mohammed Akil, et al.
Blood Reviews|September 1, 2019
The role of beta-2-glycoprotein I in health and disease associating structure with function: More than just APSThomas McDonnell, Chris Wincup, Ina Buchholz, et al.
Wellcome Open Research|December 28, 2020
Play attention! Therapeutic aspects to play in delirium prevention and managementMichaela Lynn, Bethan Goulden, Meera Parmar, et al.
Rheumatology (Oxford, England)|July 6, 2012
The BILAG2004-Pregnancy index is reliable for assessment of disease activity in pregnant SLE patientsChee-Seng Yee, Mohammed Akil, Munther Khamashta, et al.
Pageof 8